Indoco Remedies Clears UK MHRA Inspection for Goa Plant I Facility
Indoco Remedies Ltd 路 Others (Uncategorized) 路 10 Sept 2026, 6:08 pm
Indoco Remedies Clears UK MHRA Inspection for Goa Plant I Facility UK MHRA conducted a cGMP inspection at Indoco Remedies' Plant I solid oral dosage manufacturing facility in Goa from 7th Sep'26 to 9th Sep'26. The inspection concluded with zero critical or major observations. The Goa facility supplies key regulated markets, including the UK, Europe, South Africa, Australia, New Zealand, and Canada, and is projected to contribute approximately 30% of the company's total international business. The site also maintains regulatory approvals from USFDA, TGA-Australia, EU Malta (MMA), SAHPRA, and WHO-GMP.
Original exchange filing (PDF)
More announcements from Indoco Remedies Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare & Aruna Kare 路 18 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare 路 09 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Suresh G Kare 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ms. Aditi M Panandikar & Ms. Madhura Suresh Kare 路 04 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others 路 03 Nov 2026
- Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2026 路 29 Oct 2026
